1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Absenger G, Terzic J and Bezan A: ASCO
update: Lung cancer. Memo. 10:224–227. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Guo S, Luo W, Liu L, Pang X, Zhu H, Liu A,
Lu J, Ma DL, Leung CH, Wang Y and Chen X: Isocryptotanshinone, a
STAT3 inhibitor, induces apoptosis and pro-death autophagy in A549
lung cancer cells. J Drug Target. 24:934–942. 2016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Shi W, Deng J, Tong R, Yang Y, He X, Lv J,
Wang H, Deng S, Qi P, Zhang D and Wang Y: Molecular mechanisms
underlying mangiferin-induced apoptosis and cell cycle arrest in
A549 human lung carcinoma cells. Mol Med Rep. 13:3423–3432. 2016.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang L, Ruan J, Yan L, Li W, Wu Y, Tao L,
Zhang F, Zheng S, Wang A and Lu Y: Xanthatin induces cell cycle
arrest at G2/M checkpoint and apoptosis via disrupting NF-κB
pathway in A549 non-small-cell lung cancer cells. Molecules.
17:3736–3750. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chong L, Zhang W, Nie Y, Yu G, Liu L, Lin
L, Wen S, Zhu L and Li C: Protective effect of curcumin on acute
airway inflammation of allergic asthma in mice through Notch1-GATA3
signaling pathway. Inflammation. 37:1476–1485. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kukongviriyapan U, Apaijit K and
Kukongviriyapan V: Oxidative stress and cardiovascular dysfunction
associated with cadmium exposure: Beneficial effects of curcumin
and tetrahydrocurcumin. Tohoku J Exp Med. 239:25–38. 2016.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Ji JL, Huang XF and Zhu HL: Curcumin and
its formulations: Potential anti-cancer agents. Anticancer Agents
Med Chem. 12:210–218. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Han X, Deng S, Wang N, Liu Y and Yang X:
Inhibitory effects and molecular mechanisms of tetrahydrocurcumin
against human breast cancer MCF-7 cells. Food Nutr Res.
60:306162016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Yoysungnoen B, Bhattarakosol P, Changtam C
and Patumraj S: Effects of tetrahydrocurcumin on tumor growth and
cellular signaling in cervical cancer xenografts in nude mice.
Biomed Res Int 2016. 2016.doi: 10.1155/2016/1781208. View Article : Google Scholar
|
12
|
Lin B, Yu H, Lin Y, Cai C, Lu H and Zhu X:
Suppression of GRASP65 phosphorylation by tetrahydrocurcumin
protects against cerebral ischemia/reperfusion injury via ERK
signaling. Mol Med Rep. 14:4775–4780. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang Y and Qin Z: Coordination of
autophagy with other cellular activities. Acta Pharmacol Sin.
34:585–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Janku F, McConkey DJ, Hong DS and Kurzrock
R: Autophagy as a target for anticancer therapy. Nat Rev Clin
Oncol. 8:528–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zi D, Zhou ZW, Yang YJ, Huang L, Zhou ZL,
He SM, He ZX and Zhou SF: Danusertib induces apoptosis, cell cycle
arrest, and autophagy but inhibits epithelial to mesenchymal
transition involving PI3K/Akt/mTOR signaling pathway in human
ovarian cancer cells. Int J Mol Sci. 16:27228–27251. 2015.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Kang N, Wang MM, Wang YH, Zhang ZN, Cao
HR, Lv YH, Yang Y, Fan PH, Qiu F and Gao XM: Tetrahydrocurcumin
induces G2/M cell cycle arrest and apoptosis involving p38 MAPK
activation in human breast cancer cells. Food Chem Toxicol.
67:193–200. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wu JC, Lai CS, Badmaev V, Nagabhushanam K,
Ho CT and Pan MH: Tetrahydrocurcumin, a major metabolite of
curcumin, induced autophagic cell death through coordinative
modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human
leukemia HL-60 cells. Mol Nutr Food Res. 55:1646–1654. 2011.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhang XY, Zhang TT, Song DD, Zhou J, Han
R, Qin ZH and Sheng R: Endoplasmic reticulum chaperone GRP78 is
involved in autophagy activation induced by ischemic
preconditioning in neural cells. Mol Brain. 8:202015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Kuma A, Matsui M and Mizushima N: LC3, an
autophagosome marker, can be incorporated into protein aggregates
independent of autophagy: Caution in the interpretation of LC3
localization. Autophagy. 3:323–328. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bjørkøy G, Lamark T, Brech A, Outzen H,
Perander M, Overvatn A, Stenmark H and Johansen T: p62/SQSTM1 forms
protein aggregates degraded by autophagy and has a protective
effect on huntingtin-induced cell death. J Cell Biol. 171:603–614.
2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Paglin S, Lee NY, Nakar C, Fitzgerald M,
Plotkin J, Deuel B, Hackett N, McMahill M, Sphicas E, Lampen N and
Yahalom J: Rapamycin-sensitive pathway regulates mitochondrial
membrane potential, autophagy, and survival in irradiated MCF-7
cells. Cancer Res. 65:11061–11070. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kim SH, Son KM, Kim KY, Yu SN, Park SG,
Kim YW, Nam HW, Suh JT, Ji JH and Ahn SC: Deoxypodophyllotoxin
induces cytoprotective autophagy against apoptosis via inhibition
of PI3K/AKT/mTOR pathway in osteosarcoma U2OS cells. Pharmacol Rep.
69:878–884. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Pant K, Saraya A and Venugopal SK:
Oxidative stress plays a key role in butyrate-mediated autophagy
via Akt/mTOR pathway in hepatoma cells. Chem Biol Interact.
273:99–106. 2017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Shi H, Pu J, Zhou XL, Ning YY and Bai C:
Silencing long non-coding RNA ROR improves sensitivity of
non-small-cell lung cancer to cisplatin resistance by inhibiting
PI3K/Akt/mTOR signaling pathway. Tumour Biol. 39:2017.doi:
10.1177/1010428317697568. View Article : Google Scholar :
|
27
|
Jiang W, Zhang W, Wu L, Liu L, Men Y, Wang
J, Liang J, Hui Z, Zhou Z, Bi N and Wang L: MicroRNA-related
polymorphisms in PI3K/Akt/mTOR pathway genes are predictive of
limited-disease small cell lung cancer treatment outcomes. Biomed
Res Int 2017. 2017.doi: 10.1155/2017/6501385. View Article : Google Scholar
|